Nasdaq

Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.
Nasdaq

Masimo Announces CE Marking of Radius Capnography™ for the Root® Patient Monitoring and Connectivity Platform

NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius Capnography™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received CE marking ...
Becker's Hospital Review

Masimo Receives FDA Clearance for Root Patient Monitoring Platform

Masimo announced U.S. Food and Drug Administration 510(k) clearance for the Root patient monitoring and connectivity platform. The platform includes a built-in connectivity gateway through Iris for ...
Business Wire

Masimo Introduces SafetyNet™ Surveillance at HIMSS16

In 2014, Masimo introduced Root®, an intuitive open architecture patient monitoring and connectivity platform designed to speed the pace of innovation and reduce the cost of care. Masimo is also ...
Business Wire

New Study Evaluates the Ability of Masimo ORi™ to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients

In 2014, Masimo introduced Root ®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect ® (MOC-9 ®) interface, enabling other companies to augment Root with new ...
Seeking Alpha

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...